fda drug safety communication semaglutide naion 2025 use in patients with diabetes was associated with an increased risk of nonarteritic anterior ischemic optic neuropathy (NAION) at 2, 3, and 4 years. https://ja.ma/4iZkMeV The Double-Edged Sword: Ozempic For

And without the continued downward trajectory that motivated continued use, exploring alternatives with different mechanisms becomes an appealing strategy to break through stalled progress

This magnitude of improvement matches or exceeds many dedicated diabetes medications

Our team will ensure youre prepared for a smooth start to your weight loss journey, offering support throughout your treatment

Compounded medications have not been approved by the FDA for safety, effectiveness, or quality and should only be used when FDA-approved medications are unavailable

Most of the lawsuits involve claims that former users were left with gastroparesis from Ozempic or other GLP-1 medications, which involves complete stomach paralysis that impedes the movement of stomach muscles, resulting in persistent vomiting, hospitalization and other long-term health outcomes

There is no need to stop your antidepressant